|
1
|
Cadoni G, Giraldi L, Petrelli L,
Pandolfini M, Giuliani M, Paludetti G, Pastorino R, Leoncini E,
Arzani D, Almadori G and Boccia S: Prognostic factors in head and
neck cancer: A 10-year retrospective analysis in a
single-institution in Italy. Acta Otorhinolaryngol Ital.
37:458–466. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reyes-Gibby CC, Anderson KO, Merriman KW,
Todd KH, Shete SS and Hanna EY: Survival patterns in squamous cell
carcinoma of the head and neck: Pain as an independent prognostic
factor for survival. J Pain. 15:1015–1022. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barsouk A, Aluru JS, Rawla P, Saginala K
and Barsouk A: Epidemiology, risk factors, and prevention of head
and neck squamous cell carcinoma. Med Sci (Basel).
11:422023.PubMed/NCBI
|
|
4
|
Gormley M, Creaney G, Schache A,
Ingarfield K and Conway DI: Reviewing the epidemiology of head and
neck cancer: Definitions, trends and risk factors. Br Dent J.
233:780–786. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim SM: Human papilloma virus in oral
cancer. J Korean Assoc Oral Maxillofac Surg. 42:327–336. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sathish N, Wang X and Yuan Y: Human
papillomavirus (HPV)-associated oral cancers and treatment
strategies. J Dent Res. 93 (Suppl 7):29S–36S. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oliveira AC, Cavalcanti de Lima IC, Frez
Marques VM, Alves de Araújo WH and De Campos Ferreira C: Human
papillomavirus prevalence in oral and oropharyngeal squamous cell
carcinoma in South America: A systematic review and meta-analysis.
Oncol Rev. 16:5522022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Petti S: Lifestyle risk factors for oral
cancer. Oral Oncol. 45:340–350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Candotto V, Lauritano D, Nardone M, Baggi
L, Arcuri C, Gatto R, Gaudio RM, Spadari F and Carinci F: HPV
infection in the oral cavity: Epidemiology, clinical manifestations
and relationship with oral cancer. Oral Implantol (Rome).
10:209–220. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bagan J, Sarrion G and Jimenez Y: Oral
cancer: Clinical features. Oral Oncol. 46:414–417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gileva OS, Libik TV and Danilov KV: Oral
precancerous lesions: Problems of early detection and oral cancer
prevention. AIP Conf Proc. 1760:0200192016. View Article : Google Scholar
|
|
12
|
Güneri P and Epstein JB: Late stage
diagnosis of oral cancer: Components and possible solutions. Oral
Oncol. 50:1131–1136. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Baykul T, Yilmaz HH, Aydin U, Aydin MA,
Aksoy M and Yildirim D: Early diagnosis of oral cancer. J Int Med
Res. 38:737–749. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McGuirt WF: Panendoscopy as a screening
examination for simultaneous primary tumors in head and neck
cancer: A prospective sequential study and review of the
literature. Laryngoscope. 92:569–576. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fulciniti F, Califano L, Zupi A and
Vetrani A: Accuracy of fine needle aspiration biopsy in head and
neck tumors. J Oral Maxillofac Surg. 55:1094–1097. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Burkill GJC, Evans RM, Raman VV and Connor
SEJ: Modern radiology in the management of head and neck cancer.
Clin Oncol (R Coll Radiol). 28:440–450. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dai YL and King AD: State of the art MRI
in head and neck cancer. Clin Radiol. 73:45–59. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Irani S: Distant metastasis from oral
cancer: A review and molecular biologic aspects. J Int Soc Prev
Community Dent. 6:265–271. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
El-Naaj IA, Leiser Y, Shveis M, Sabo E and
Peled M: Incidence of oral cancer occult metastasis and survival of
T1-T2N0 oral cancer patients. J Oral Maxillofac Surg. 69:2674–2679.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zanoni DK, Patel SG and Shah JP: Changes
in the 8th edition of the American joint committee on cancer (AJCC)
staging of head and neck cancer: Rationale and implications. Curr
Oncol Rep. 21:522019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shah JP and Gil Z: Current concepts in
management of oral cancer-surgery. Oral Oncol. 45:394–401. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang SH and O'Sullivan B: Oral cancer:
Current role of radiotherapy and chemotherapy. Med Oral Patol Oral
Cir Bucal. 18:e233–e240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lang K, Baur M, Held T, Shafie RE, Moratin
J, Freudlsperger C, Zaoui K, Bougatf N, Hoffmann J, Plinkert PK, et
al: Definitive radiotherapy for squamous cell carcinoma of the oral
cavity: A single-institution experience. Radiol Oncol. 55:467–473.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hartner L: Chemotherapy for oral cancer.
Dent Clin North Am. 62:87–97. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kimura I, Kitahara H, Ooi K, Kato K,
Noguchi N, Yoshizawa K, Nakamura H and Kawashiri S: Loss of
epidermal growth factor receptor expression in oral squamous cell
carcinoma is associated with invasiveness and
epithelial-mesenchymal transition. Oncol Lett. 11:201–207. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang T, Sun S, Zeng X and Li J: ICI-based
therapies: A new strategy for oral potentially malignant disorders.
Oral Oncol. 140:1063882023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Doumas S, Foukas PG, Economopoulou P,
Kotsantis I and Psyrri A: Atypical patterns of responses in the era
of immune checkpoint inhibitors in head and neck cancer. Oral
Oncol. 100:1044772020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mohanty V, Subbannayya Y, Patil S,
Puttamallesh VN, Najar MA, Datta KK, Pinto SM, Begum S, Mohanty N,
Routray S, et al: Molecular alterations in oral cancer using
high-throughput proteomic analysis of formalin-fixed
paraffin-embedded tissue. J Cell Commun Signal. 15:447–459. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tokuzen N, Nakashiro KI, Tojo S, Goda H,
Kuribayashi N and Uchida D: Human papillomavirus-16 infection and
p16 expression in oral squamous cell carcinoma. Oncol Lett.
22:5282021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vergori A, Garbuglia AR, Piselli P, Del
Nonno F, Sias C, Lupi F, Lapa D, Baiocchini A, Cimaglia C, Gentile
M, et al: Oral human papillomavirus DNA detection in HIV-positive
men: Prevalence, predictors, and co-occurrence at anal site. BMC
Infect Dis. 18:252018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sritippho T, Chotjumlong P and Iamaroon A:
Roles of human papillomaviruses and p16 in oral cancer. Asian Pac J
Cancer Prev. 16:6193–6200. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Castro TPPG and Bussoloti Filho I:
Prevalence of human papillomavirus (HPV) in oral cavity and
oropharynx. Braz J Otorhinolaryngol. 72:272–281. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Katirachi SK, Grønlund MP, Jakobsen KK,
Grønhøj C and von Buchwald C: The prevalence of HPV in oral cavity
squamous cell carcinoma. Viruses. 15:4512023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Doll C, Steffen C, Beck-Broichsitter B,
Richter M, Neumann K, Pohrt A, Lohneis P, Lehmann A, Heiland M,
Stromberger C, et al: The prognostic significance of p16 and its
role as a surrogate marker for human papilloma virus in oral
squamous cell carcinoma: An analysis of 281 cases. Anticancer Res.
42:2405–2413. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Christianto S, Li KY, Huang TH and Su Y:
The prognostic value of human papilloma virus infection in oral
cavity squamous cell carcinoma: A meta-analysis. Laryngoscope.
132:1760–1770. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Miranda-Galvis M, Rumayor Piña A, Sales de
Sá R, Almeida Leite A, Agustin Vargas P, Calsavara VF, Lópes Pinto
CA, Teng Y and Kowalski LP: PD-L1 expression patterns in oral
cancer as an integrated approach for further prognostic
classification. Oral Dis. 27:1699–1710. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lenouvel D, González-Moles MÁ, Ruiz-Ávila
I, Chamorro-Santos C, González-Ruiz L, González-Ruiz I and
Ramos-García P: Clinicopathological and prognostic significance of
PD-L1 in oral cancer: A preliminary retrospective
immunohistochemistry study. Oral Dis. 27:173–182. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dave K, Ali A and Magalhaes M: Increased
expression of PD-1 and PD-L1 in oral lesions progressing to oral
squamous cell carcinoma: A pilot study. Sci Rep. 10:97052020.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu T, Tang C, Tao R, Yong X, Jiang Q and
Feng C: PD-L1-mediated immunosuppression in oral squamous cell
carcinoma: Relationship with macrophage infiltration and epithelial
to mesenchymal transition markers. Front Immunol. 12:6938812021.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Burtness B, Harrington KJ, Greil R,
Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane
P, Bratland Å, et al: Pembrolizumab alone or with chemotherapy
versus cetuximab with chemotherapy for recurrent or metastatic
squamous cell carcinoma of the head and neck (KEYNOTE-048): A
randomised, open-label, phase 3 study. Lancet. 394:1915–1928. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ries J, Agaimy A, Wehrhan F, Baran C,
Bolze S, Danzer E, Frey S, Jantsch J, Möst T, Büttner-Herold M, et
al: Importance of the PD-1/PD-L1 axis for malignant transformation
and risk assessment of oral leukoplakia. Biomedicines. 9:1942021.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vermorken JB, Mesia R, Rivera F, Remenar
E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol
D, et al: Platinum-based chemotherapy plus cetuximab in head and
neck cancer. N Engl J Med. 359:1116–1127. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Botticelli A, Cirillo A, Strigari L,
Valentini F, Cerbelli B, Scagnoli S, Cerbelli E, Zizzari IG, Rocca
CD, D'Amati G, et al: Anti-PD-1 and anti-PD-L1 in head and neck
cancer: A network meta-analysis. Front Immunol. 12:7050962021.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fasano M, Corte CMD, Liello RD, Viscardi
G, Sparano F, Iacovino ML, Paragliola F, Piccolo A, Napolitano S,
Martini G, et al: Immunotherapy for head and neck cancer: Present
and future. Crit Rev Oncol Hematol. 174:1036792022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wongpattaraworakul W, Gibson-Corley KN,
Choi A, Buchakjian MR, Lanzel EA, Rajan Kd A and Simons AL:
Prognostic role of combined EGFR and tumor-infiltrating lymphocytes
in oral squamous cell carcinoma. Front Oncol. 12:8852362022.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen IH, Chang JT, Liao CT, Wang HM, Hsieh
LL and Cheng AJ: Prognostic significance of EGFR and Her-2 in oral
cavity cancer in betel quid prevalent area cancer prognosis. Br J
Cancer. 89:681–686. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kang JJ, Ko A, Kil SH, Mallen-St Clair J,
Shin DS, Wang MB and Srivatsan ES: EGFR pathway targeting drugs in
head and neck cancer in the era of immunotherapy. Biochim Biophys
Acta Rev Cancer. 1878:1888272023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bossi P, Resteghini C, Paielli N, Licitra
L, Pilotti S and Perrone F: Prognostic and predictive value of EGFR
in head and neck squamous cell carcinoma. Oncotarget.
7:74362–74379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Moharil R, Khandekar S, Dive A and Bodhade
A: Cyclin D1 in oral premalignant lesions and oral squamous cell
carcinoma: An immunohistochemical study. J Oral Maxillofac Pathol.
24:3972020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lam KY, Ng IO, Yuen AP, Kwong DL and Wei
W: Cyclin D1 expression in oral squamous cell carcinomas:
Clinicopathological relevance and correlation with p53 expression.
J Oral Pathol Med. 29:167–172. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ahmed MAS, Omer N, Suliman AM and Ellaithi
M: Expression of cyclin D1 in oral squamous cell carcinoma. Sudan J
Med Sci. 16:558–566. 2021.
|
|
52
|
Saawarn S, Astekar M, Saawarn N, Dhakar N
and Gomateshwar Sagari S: Cyclin D1 expression and its correlation
with histopathological differentiation in oral squamous cell
carcinoma. ScientificWorldJournal. 2012:9783272012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Acero-Mondragón E, Rodríguez-Farías R,
Salazar-Hernández M and Figueroa-Avendaño J: Histological
correlation of Ki-67 and D1 cycline markers expression in squamous
cell carcinoma in the oral cavity. Rev Odontol Mex. 20:e225–e229.
2016. View Article : Google Scholar
|
|
54
|
Ramos-García P, González-Moles MÁ,
González-Ruiz L, Ayén Á, Ruiz-Ávila I, Bravo M and Gil-Montoya JA:
Clinicopathological significance of tumor cyclin D1 expression in
oral cancer. Arch Oral Biol. 99:177–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Huang SF, Cheng SD, Chuang WY, Chen IH,
Liao CT, Wang HM and Hsieh LL: Cyclin D1 overexpression and poor
clinical outcomes in Taiwanese oral cavity squamous cell carcinoma.
World J Surg Oncol. 10:402012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Awawdeh MA, Sasikumar R, Aboalela AA,
Siddeeqh S, Gopinathan PA, Sawair F and Khanagar SB: Evaluation of
prognostic significance of the expression of p53, cyclin D1, EGFR
in advanced oral squamous cell carcinoma after chemoradiation-A
systematic review. Appl Sci. 13:52922023. View Article : Google Scholar
|
|
57
|
Takkem A, Barakat C, Zakarea S, Zaid K,
Najmeh J, Ayoub M and Seirawan MY: Ki-67 prognostic value in
different histological grades of oral epithelial dysplasia and oral
squamous cell carcinoma. Asian Pac J Cancer Prev. 19:3279–3286.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Davey MG, Hynes SO, Kerin MJ, Miller N and
Lowery AJ: Ki-67 as a prognostic biomarker in invasive breast
cancer. Cancers (Basel). 13:44552021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li LT, Jiang G, Chen Q and Zheng JN: Ki67
is a promising molecular target in the diagnosis of cancer
(review). Mol Med Rep. 11:1566–1572. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Xie S, Liu Y, Qiao X, Hua RX, Wang K, Shan
XF and Cai ZG: What is the prognostic significance of Ki-67
positivity in oral squamous cell carcinoma? J Cancer. 7:758–767.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Meyer HJ, Gundermann P and Surov A:
Associations between FDG-PET and Ki 67-index in head and neck
cancer: A meta-analysis. Medicine (Baltimore). 98:e174722019.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Lopes VKM, de Jesus AS, de Souza LL,
Miyahara LAN, Guimarães DM, Pontes HAR, Pontes FSC and Carvalho PL:
Ki-67 protein predicts survival in oral squamous carcinoma cells:
An immunohistochemical study. Braz Oral Res. 31:e662017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Mohamed AA, EL-Shall OS and EL-Kilani NS:
Role of expression Ki-67 in diagnosis of oral cancer. Al-Azhar Dent
J Girls. 7:441–445. 2020. View Article : Google Scholar
|
|
64
|
Govindaraj PK, Kallarakkal TG, Mohd Zain
R, Tilakaratne WM and Lew HL: Expression of Ki-67, Cornulin and
ISG15 in non-involved mucosal surgical margins as predictive
markers for relapse in oral squamous cell carcinoma (OSCC). PLoS
One. 16:e02615752021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Pan W, Zhang C, Chen M, Min S, Xu L and
Chi Z: Expression of Ki-67 and P16 are related with HPV in squamous
cell carcinoma of the external auditory canal. J Otolaryngol Head
Neck Surg. 51:402022. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Jun W, Shaobo O, Xianhua Z, Siyu Z,
Mingyang C, Xin F, Ying C and Lan L: Deregulation of
hsa_circ_0001971/miR-186 and hsa_circ_0001874/miR-296 signaling
pathways promotes the proliferation of oral squamous carcinoma
cells by synergistically activating SHP2/PLK1 signals. Sci Rep.
11:205612021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Murase R, Abe Y, Takeuchi T, Nabeta M,
Imai Y, Kamei Y, Kagawa-Miki L, Ueda N, Sumida T, Hamakawa H and
Kito K: Serum autoantibody to sideroflexin 3 as a novel tumor
marker for oral squamous cell carcinoma. Proteomics Clin Appl.
2:517–527. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Mauro C, Passerini R, Spaggiari L, Galetta
D, Radice D, Lentati P and Sandri MT: New and old biomarkers in the
differential diagnosis of lung cancer: Pro-gastrin-releasing
peptide in comparison with neuron-specific enolase,
carcinoembryonic antigen, and CYFRA 21-1. Int J Biol Markers.
34:163–167. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Deepa T and Thirrunavukkarasu N: Saliva as
a potential diagnostic tool. Indian J Med Sci. 64:293–306. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Johnstone S and Logan RM: The role of
vascular endothelial growth factor (VEGF) in oral dysplasia and
oral squamous cell carcinoma. Oral Oncol. 42:337–342. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Edirisinghe ST, Weerasekera M, De Silva
DK, Devmini MT, Pathmaperuma S, Wijesinghe GK, Nisansala T,
Maddumage A, Huzaini H, Rich AM, et al: Vascular endothelial growth
factor A (VEGF-A) and vascular endothelial growth factor receptor 2
(VEGFR-2) as potential biomarkers for oral squamous cell carcinoma:
A Sri Lankan study. Asian Pac J Cancer Prev. 24:267–274. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kim SK, Park SG and Kim KW: Expression of
vascular endothelial growth factor in oral squamous cell carcinoma.
J Korean Assoc Oral Maxillofac Surg. 41:11–18. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Loh CY, Chai JY, Tang TF, Wong WF, Sethi
G, Shanmugam MK, Chong PP and Looi CY: The E-cadherin and
N-cadherin switch in epithelial-to-mesenchymal transition:
Signaling, therapeutic implications, and challenges. Cells.
8:11182019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Alsafadi R and Manadili A: The correlation
between CD44 and angiogenesis in oral squamous cell carcinoma
induced in buccal pouch in syrian hamster that underwent
radiotherapy. Asian Pac J Cancer Prev. 23:3571–3576. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Zhang CZ, Cheng XQ, Li JY, Zhang P, Yi P,
Xu X and Zhou XD: Saliva in the diagnosis of diseases. Int J Oral
Sci. 8:133–137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Roi A, Rusu LC, Roi CI, Luca RE, Boia S
and Munteanu RI: A new approach for the diagnosis of systemic and
oral diseases based on salivary biomolecules. Dis Markers.
2019:87618602019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Goldoni R, Scolaro A, Boccalari E, Dolci
C, Scarano A, Inchingolo F, Ravazzani P, Muti P and Tartaglia G:
Malignancies and biosensors: A focus on oral cancer detection
through salivary biomarkers. Biosensors (Basel). 11:3962021.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Konings H, Stappers S, Geens M, De Winter
BY, Lamote K, van Meerbeeck JP, Specenier P, Vanderveken OM and
Ledeganck KJ: A literature review of the potential diagnostic
biomarkers of head and neck neoplasms. Front Oncol. 10:10202020.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Rajkumar K, Ramya R, Nandhini G, Rajashree
P, Ramesh Kumar A and Nirmala Anandan S: Salivary and serum level
of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
Oral Dis. 21:90–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Liu L, Xie W, Xue P, Wei Z, Liang X and
Chen N: Diagnostic accuracy and prognostic applications of CYFRA
21-1 in head and neck cancer: A systematic review and
meta-analysis. PLoS One. 14:e02165612019. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Liu Y, Cao Y, He S and Cai W: Technical
and clinical performance of two methods to detect squamous cell
carcinoma antigen levels for comparing pathological diagnosis
coincidence rates in lung, cervical, and head and neck cancers.
Clin Lab. 66:2020. View Article : Google Scholar
|
|
82
|
Yasumatsu R, Nakano T, Hashimoto K, Kogo
R, Wakasaki T and Nakagawa T: The clinical value of serum squamous
cell carcinoma antigens 1 and 2 in head and neck squamous cell
carcinoma. Auris Nasus Larynx. 46:135–140. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Obata K, Yutori H, Yoshida K, Sakamoto Y,
Ono K and Ibaragi S: Relationships between squamous cell carcinoma
antigen and cytokeratin 19 fragment values and renal function in
oral cancer patients. Int J Oral Maxillofac Surg. 52:417–422. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Lin D, Shen L, Luo M, Zhang K, Li J, Yang
Q, Zhu F, Zhou D, Zheng S, Chen Y and Zhou J: Circulating tumor
cells: Biology and clinical significance. Signal Transduct Target
Ther. 6:4042021. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Deng Z, Wu S, Wang Y and Shi D:
Circulating tumor cell isolation for cancer diagnosis and
prognosis. EBioMedicine. 83:1042372022. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Kulasinghe A, Hughes BGM, Kenny L and
Punyadeera C: An update: Circulating tumor cells in head and neck
cancer. Expert Rev Mol Diagn. 19:1109–1115. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Perumal V, Corica T, Dharmarajan A, Sun Z,
Dhaliwal SS, Dass CR and Dass J: Circulating tumour cells (CTC),
head and neck cancer and radiotherapy; future perspectives. Cancers
(Basel). 11:3672019. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Liskova A, Samec M, Koklesova L, Giordano
FA, Kubatka P and Golubnitschaja O: Liquid biopsy is instrumental
for 3PM dimensional solutions in cancer management. J Clin Med.
9:27492020. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Anjum A, Shree R.VB, Jayaram Thambiah L
and Rodrigues C: A comparitive and prognostic study of circulating
tumor cells and vegfr-2 in different histological grades of oral
squamous cell carcinoma. Int J Adv Res. 10:745–754. 2022.
View Article : Google Scholar
|
|
90
|
Qayyumi B, Bharde A, Aland G, D'Souza A,
Jayant S, Singh N, Tripathi S, Badave R, Kale N, Singh B, et al:
Circulating tumor cells as a predictor for poor prognostic factors
and overall survival in treatment naïve oral squamous cell
carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol.
134:73–83. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Gauthier A, Philouze P, Lauret A, Alphonse
G, Malesys C, Ardail D, Payen L, Céruse P, Wozny AS and
Rodriguez-Lafrasse C: Circulating tumor cell detection during
neoadjuvant chemotherapy to predict early response in locally
advanced oropharyngeal cancers: A prospective pilot study. J Pers
Med. 12:4452022. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Curtin J, Thomson P, Wong G, Lam A and
Choi SW: The impact of surgery on circulating malignant tumour
cells in oral squamous cell carcinoma. Cancers (Basel). 15:5842023.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zhang X, Ekanayake Weeramange C, Hughes
BGM, Vasani S, Liu ZY, Warkiani ME, Hartel G, Ladwa R, Thiery JP,
Kenny L and Punyadeera C: Application of circulating tumour cells
to predict response to treatment in head and neck cancer. Cell
Oncol (Dordr). 45:543–555. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Sahibzada HA, Khurshid Z, Khan RS, Naseem
M, Siddique KM, Mali M and Zafar MS: Salivary IL-8, IL-6 and TNF-α
as potential diagnostic biomarkers for oral cancer. Diagnostics
(Basel). 7:212017. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Khurshid Z, Zafar MS, Khan RS, Najeeb S,
Slowey PD and Rehman IU: Role of salivary biomarkers in oral cancer
detection. Advances in Clinical Chemistry. Vol. 86. Elsevier; pp.
pp23–70. 2018, http://dx.doi.org/10.1016/bs.acc.2018.05.002
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Khurshid Z, Warsi I, Moin SF, Slowe PD,
Latif M, Zohaib S and Zafar MS: Biochemical analysis of oral fluids
for disease detection. Advances in Clinical Chemistry. Vol. 100.
Elsevier; pp. pp205–253. 2021, http://dx.doi.org/10.1016/bs.acc.2020.04.005
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Chu HW, Chang KP, Hsu CW, Chang IY, Liu
HP, Chen YT and Wu CC: Identification of salivary biomarkers for
oral cancer detection with untargeted and targeted quantitative
proteomics approaches. Mol Cell Proteomics. 18:1796–1806. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Chiamulera MMA, Zancan CB, Remor AP,
Cordeiro MF, Gleber-Netto FO and Baptistella AR: Salivary cytokines
as biomarkers of oral cancer: A systematic review and
meta-analysis. BMC Cancer. 21:2052021. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
St John MA, Li Y, Zhou X, Denny P, Ho CM,
Montemagno C, Shi W, Qi F, Wu B, Sinha U, et al: Interleukin 6 and
interleukin 8 as potential biomarkers for oral cavity and
oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck
Surg. 130:929–935. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Cheng YSL, Rees T and Wright J: A review
of research on salivary biomarkers for oral cancer detection. Clin
Transl Med. 3:32014. View Article : Google Scholar : PubMed/NCBI
|
